Jubilant Pharma Limited, Singapore, a wholly owned subsidiary of Jubilant Pharmova, has announced a significant financial move by selling its entire 25.8% stake in Sofie Biosciences Inc., USA, for a total of approximately USD 139.43 million, including preferred returns. Jubilant Pharma initially invested USD 25 million in Sofie Biosciences in November 2020. Sofie, a company […]
Jubilant Pharmova said that its subsidiary Jubilant HollisterStier, a Canada-based pharmaceutical contract manufacturing organization (CMO) has secured a loan of CAD 23.8 million from the Canadian government for the capacity expansion of its Montreal manufacturing facility. The loan, which will be partially repayable, will be provided through the government’s Strategic Innovation Fund (SIF) program. Jubilant […]
Jubilant Pharmova said that the US Food and Drug Administration (FDA) has determined the inspection classification of its solid dosage manufacturing facility in Roorkee, Uttarakhand. The communication by the FDA was given to the company’s fully-owned subsidiary Jubilant Pharma’s subsidiary Jubilant Generics Limited (JGL). The inspection classification of the solid dosage manufacturing facility has been […]
Jubilant Pharmova said that its fully-owned subsidiary – Jubilant Pharma will invest $92 million to expand its manufacturing capacity of sterile injections at its Spokane site in Washington state. The investment will enable Jubilant Pharma to install a high speed injectable fill line with isolator technology that can produce 400 vials a minute, thereby boosting […]